OTC Pharmaceuticals - Gabon

  • Gabon
  • The OTC Pharmaceuticals market in Gabon generated a revenue of US$38.60m in 2024.
  • It is projected to experience an annual growth rate of 3.36% (CAGR 2024-2029).
  • Among the various markets, the Other OTC Pharmaceuticals market is the largest, with a market volume of US$14.66m in 2024.
  • When compared globally, the in the United States leads in revenue generation, with a total of US$41,240.00m in 2024.
  • Taking into account the country's population, per person revenues in Gabon amounted to US$15.54 in 2024.
  • Furthermore, online sales are expected to contribute 2.34% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Gabon's OTC Pharmaceuticals market is witnessing a growing demand for traditional herbal remedies due to cultural beliefs and limited access to healthcare facilities.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Gabon is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to the positive trajectory of the market.Customer preferences in Gabon are shifting towards self-medication and easy access to healthcare products. With the increasing awareness about healthcare and wellness, consumers are becoming more proactive in managing their own health. This has led to a growing demand for over-the-counter (OTC) pharmaceuticals, as they provide convenient and affordable solutions for common health issues. Customers prefer OTC medications that are easily accessible, reliable, and offer quick relief from symptoms.Trends in the OTC Pharmaceuticals market in Gabon are aligned with global trends. The market is witnessing a rise in the availability and variety of OTC products. This is driven by the entry of multinational pharmaceutical companies and the expansion of local manufacturers. The introduction of new OTC medications and the expansion of product portfolios are catering to the diverse needs of consumers. Additionally, the market is witnessing a shift towards natural and herbal remedies, as consumers are increasingly seeking alternative and holistic healthcare solutions.Local special circumstances in Gabon also contribute to the development of the OTC Pharmaceuticals market. The country has a growing middle class with increasing disposable income, which has led to higher healthcare spending. Moreover, the government has implemented policies to promote the development of the pharmaceutical industry, including the establishment of regulatory frameworks and the promotion of local manufacturing. These initiatives have created a conducive environment for the growth of the OTC Pharmaceuticals market.Underlying macroeconomic factors further support the growth of the OTC Pharmaceuticals market in Gabon. The country's stable economic growth and improving healthcare infrastructure have increased access to healthcare services, including OTC medications. Additionally, the rising prevalence of chronic diseases and lifestyle-related health issues has created a demand for OTC pharmaceuticals. The market is also benefiting from the increasing urbanization and changing demographics, as urban populations have higher healthcare needs and are more likely to seek OTC remedies.In conclusion, the OTC Pharmaceuticals market in Gabon is experiencing significant growth and development. Customer preferences for self-medication and easy access to healthcare products, along with global trends, are driving the market. Local special circumstances, such as the growing middle class and government initiatives, are also contributing to the market's growth. Underlying macroeconomic factors, including stable economic growth and improving healthcare infrastructure, further support the positive trajectory of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)